NCT06202911View on ClinicalTrials.gov

Effect of Oral N-Acetyl Cysteine in Prevention of Necrotizing Enterocolitis in Preterm Neonates With Feeding Intolerance

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

March 30, 2024

Study Completion Date

March 30, 2024

Conditions

Preterm Neonates and Feeding IntoleranceNecrotizing EnterocolitisOral N-acetyl Cysteine

Interventions

DRUG

oral n-acetyl cysteine

the active participants will receive oral N-acetyl cysteine with dose 20mg/dose every 6 hours for 10 days or until reaching full feeding or resolution of feeding intolerance

OTHER

placebo

the control group will receive placebo

Trial Locations (1)

1234

Ain Shams university hospitals, Cairo

All Listed Sponsors

lead

Ain Shams University

OTHER